Efficacy and Safety of Ocrelizumab Vs Interferon Beta-1A in Participants of African Descent with Relapsing Multiple Sclerosis in the Phase III OPERA I and OPERA II Studies.
Multiple sclerosis and related disorders（2021）
关键词
Interferon beta-1a,Ocrelizumab,Multiple sclerosis,African,Subgroup
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要